Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress ...Middle East

News by : (PR Newswire) -
OSLO, Norway, Oct. 12, 2023 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has today unveiled the results of its Hexvix® (APL-1706) Phase III clinical trial in China. A presentation scheduled for today...

Hence then, the article about positive results for hexvix phase iii clinical trial in china presented at the siu 2023 congress was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار